Dose Comparisons of Clopidogrel and Aspirin in Acute Coronary Syndromes | Zendy

Shamir R. Mehta | Zendy; JeanPierre Bassand | Zendy; Susan Chrolavicius | Zendy; Rafael Díaz | Zendy; John W. Eikelboom | Zendy; Keith A.A. Fox | Zendy; Christopher B. Granger | Zendy; Sanjit S. Jolly | Zendy; Campbell Joyner | Zendy; HansJürgen Rupprecht | Zendy; Petr Widimský | Zendy; Rizwan Afzal | Zendy; Janice Pogue | Zendy; Salim Yusuf | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Dose Comparisons of Clopidogrel and Aspirin in Acute Coronary Syndromes

Author(s) -

Shamir R. Mehta,

JeanPierre Bassand,

Susan Chrolavicius,

Rafael Díaz,

John W. Eikelboom,

Keith A.A. Fox,

Christopher B. Granger,

Sanjit S. Jolly,

Campbell Joyner,

HansJürgen Rupprecht,

Petr Widimský,

Rizwan Afzal,

Janice Pogue,

Salim Yusuf

Publication year - 2010

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa0909475

Subject(s) - medicine , clopidogrel , aspirin , percutaneous coronary intervention , hazard ratio , conventional pci , loading dose , maintenance dose , myocardial infarction , acute coronary syndrome , confidence interval , cardiology , surgery

Clopidogrel and aspirin are widely used for patients with acute coronary syndromes and those undergoing percutaneous coronary intervention (PCI). However, evidence-based guidelines for dosing have not been established for either agent.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research